Zacks Investment Research upgraded shares of IPC THE HOSPITL (IPCM) from UNDERPERFORM to NEUTRAL on December 26, 2012, with a target price of $41.10.
IPC THE HOSPITALIST COMPANY, INC. is a leading provider of hospitalist services in the United States. IPC's physicians manage and coordinate the care of hospitalized patients and serve as the inpatient partner of primary care physicians and specialists. IPC assists hospitals and payors in improving quality of inpatient care, increasing operating efficiencies and reducing costs. The Company provides its hospitalists with the management systems, information technology, training and administrative support necessary to perform these services.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on IPC THE HOSPITL (IPCM),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment